Coffee and Collaboration in ASH Central (for in-person participants) How I Treat: Bringing Science to Clinical Dilemmas (for in-person participants) Meet the Scientist (for in-person participants) 9:00A.M - 9:30A.M Coff...
101A Multi-Omic Single-Cell Landscape of Cytokine Release Syndrome in Multiple Myeloma Patients after Anti-BCMA CAR-T Cell Therapy 胡永仙，浙江大学医学院附属第一医院 117Discovery of BCL-XL Heterobifunctional Degrader with Potentially Improved Therapeutic Window and Minimal Platelet Toxicity for Hematolog...
叶逸山,浙江大学医学院附属第一医院 686Integrin αvβ8-Mediated Activation of TGF-β1 Is Involved in Regulating the Sustained Response after TPO-Ras Withdrawal in ITP Patients Min Xu,华中科技大学同济医学院附属协和医院 687Efficacy and Safety of Human Umbilical Cord-Derived Mesenchymal Stem Cells in ...
以上述临床问题为导向,华中科技大学附属协和医院梅恒/胡豫教授与上海交通大学刘峻岭教授团队合作在嵌合抗原受体T细胞(Chimeric antigen receptor T cells,CAR-T)疗法的基础上,开发了针对ITP的世界首个嵌合自身抗体受体T细胞(chimeric autoantibody re...
In response to a question about how to address both intentional and unintentional bias in AI, Altman said there are very smart people actively working on algorithmic approaches to identifying and removing bias in AI. Bias can be measured and subtracted out in other systems, so Altman is hopeful...
1212 - The Lack of Tolerable Treatment Options That Can Induce Durable Responses without Fear of Relapse after Discontinuation Represents a Significant Unmet Need for Patients (Pts) with Immune Thrombocytopenia (ITP): Results from the ITP World Impact Survey (I-WISh) 2.0 Abi...